Primer | Forward primer | Reverse primer |
CXCL1 | 5′-GCTTGAAGGTGTTGCCCTCAG-3′ | 5′-AAGCCTCGCGACCATTCTTG-3′ |
CXCL13 | 5′-CATAGATCGGATTCAAGT-3′ | 5′-TCTTGGTCCAGATCACAA-3′ |
CXCR5 | 5′-TGGCCTTCTACAGTAACAGCA-3′ | 5′-GCATGAATACCGCCTTAAAGGAC-3′ |
Sox4 | 5′-GCCTCCATCTTCGTACAACC-3′ | 5′-AGTGAAGCGCGTCTACCTGT-3′ |
Bcl-6 | 5′-CCGGCACGCTAGTGATGTT-3′ | 5′-TGTCTTATGGGCTCTAAACTGCT-3′ |
GAPDH | 5′-CCAGTAGACTCCACGACATACTCA-3′ | 5′-ATCAACGACCCCTTCATTGACC-3′ |
Bcl-6, B-Cell CLL/Lymphoma 6; CXCL, chemokine CXC ligand; CXCR5, CXC-chemokine receptor type 5; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; Sox4, SRY-related HMG box4.